Hans-Peter Kiem, MD, FACP

Dr. Kiem conducts preclinical and clinical studies of gene therapy. His clinical interests are hematopoietic stem cell transplantation, gene therapy, and graft-versus-host disease.

Title

• José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research, Clinical Research Division, Fred Hutchinson Cancer Research Center
• Member, Clinical Research Division, Transplantation Biology Program, Fred Hutchinson Cancer Research Center
• Professor, School Of Medicine, University of Washington School of Medicine

Clinical Expertise

Hematopoietic stem cell transplantation and gene therapy, graft-versus-host disease

Education And Training

• MD: University of Ulm, Medicine, 1987
• Dr.med: University of Ulm, Medicine, 1988
  Internal Medicine
• Residency: Vanderbilt University 1990-1992
• Fellowships: Stanford University 1988-1990, University of Washington, FHCRC 1992-1995

More Information

For more information about Dr. Hans-Peter Kiem's clinical and research expertise, click here.

Clinical Trials

• Chemotherapy Plus Chemoprotected Autologous Stem Cells for Malignant Gliomas (FHCRC-2000)